AlmaLinux vulnerabilities: known CVEs & security history
AlmaLinux · OS / Linux · 6 tracked CVEs · 0 actively exploited · updated June 2026 · what is a CVE? →
This is the full list of known vulnerabilities (CVEs) across all AlmaLinux release lines — 6 in total. A CVE here doesn't mean your version is affected — check AlmaLinux's current status and the safe version to run.
Known AlmaLinux CVEs
Actively-exploited and most-severe first. Open any CVE for full details.
| CVE | Severity | CVSS | EPSS | Year |
|---|---|---|---|---|
| CVE-2024-12084 | critical | 9.8 | 72% | 2025 |
| CVE-2024-6387 | high | 8.1 | 100% | 2024 |
| CVE-2024-12085 | high | 7.5 | 9% | 2025 |
| CVE-2024-12088 | medium | 6.5 | 5% | 2025 |
| CVE-2024-12087 | medium | 6.5 | 2% | 2025 |
| CVE-2024-12086 | medium | 6.1 | 2% | 2025 |
Is my AlmaLinux version affected?
The list above spans every release. To know whether your version is affected — and the minimum safe version to upgrade to — check it directly.
Check your AlmaLinux version → · Monitor AlmaLinux for new CVEs →
AlmaLinux vulnerabilities — frequently asked
How many known vulnerabilities does AlmaLinux have?
IsItPatched tracks 6 CVEs for AlmaLinux. 1 is critical-severity and 2 high-severity. These span every release line — what matters is whether the version you run is affected.
Does AlmaLinux have any actively-exploited vulnerabilities?
None of AlmaLinux's tracked CVEs are currently in CISA's KEV catalog — but new ones can be added at any time, so keep your version current.
What is the most severe AlmaLinux vulnerability?
Among tracked issues, CVE-2024-12084 (CRITICAL, CVSS 9.8) ranks highest — a CWE-122 weakness.
Is AlmaLinux safe to use?
It depends on the version. The latest supported AlmaLinux release (10.2) clears the known issues; older versions may still be affected. Check the exact version you run for a verdict.
CVE data aggregated from NVD, CISA KEV and EPSS (FIRST.org). Related: AlmaLinux security status · AlmaLinux end-of-life · actively-exploited CVEs. Always verify against AlmaLinux's advisories — see our disclaimer.